Our people

Gill
Founder of TIGCRU Insight. With 20 years’ experience in pharmaceutical strategic marketing, Gill has led teams and projects to utilize Market Research, Competitive Intelligence and Insights to better understand, and anticipate, their commercial context and ultimately meet customer needs.
Gill has a passion for getting the best out of people and teams, and is often seen facilitating workshops to help clients navigate towards, land on, and feel proud in owning their decisions.
One example of where Gill brings these skills together, is in providing consulting support to clients on evaluating and integrating Personalised Healthcare approaches into product development strategies, an area she has been actively involved in since 2009.

MBTI Practitioner; NLP Business Practitioner.

Gill

Mark
Mark has worked in pharma for 16 years. He is one of those rare people who is great at blending analytical and creative thinking skills when tackling a challenge. As comfortable developing a forecast model as running a creative workshop. He is valued by clients for his pragmatic solutions. His passion is Brand Planning, and his secret – start with the end in mind!
A scientist by training, Mark has ‘carried the bag’ as a Rep for two years and held various Business Analyst and Marketing roles in both local and global marketing organisations. Mark has worked across all stages of the product life cycle and across several disease areas.

Mark

Sue
Having led Insight support through the launch of CRESTOR, Sue brings a wealth of Insight and project management experience. Sue is well-versed in managing projects to deliver against expectations of various internal governance bodies.
She has a passion for integrating learning and ensuring all customer groups are considered in unearthing insights - always with an eye on the ‘red thread’ to the business decision.
With 20 years' pharma experience, 13 of which were in commercial roles, Sue brings preparation for and launch of global brands skill to the team.

Sue

Peter
Peter draws from over 20 years’ experience in the pharmaceutical industry with roles spanning the complete lifecycle, drug development through to sales. His key skills are drawing on a diverse range of inputs and forging these into meaningful recommendations that corporations can act on with confidence. Whether it is running multinational brand equity based positioning studies or finding the nuances to future drug markets and producing validated financial forecasts for new opportunities, Peter is in his element.
His commercial roles have included development brand teams, inline brand teams (CRESTOR), portfolio planning, strategic marketing, corporate planning and GP/Hospital sales.

Peter

Lynda
Lynda's 17 years of client and agency work has spanned different therapy areas and global commercial functions including business insight, market research, product strategy and licensing.
She is an experienced facilitator who brings an enthusiastic, engaging approach to leading and facilitating marketing workshops and learning sessions.
Her role as Business Insight Director, saw her lead a team in the generation of customer and competitor insights that defined business opportunities, shaped clinical trial design and delivered competitive differentiation at launch for key brands.

Lynda

Bob
Bob is a high profile healthcare market research leader with over 30 years' experience within the healthcare sector. He has held a number of senior management roles in leading global market research agencies, including Ipsos and TNS (Now Kantar Health). He also understands how to apply research findings from the client perspective, having worked for Boehringer Ingelheim, Roche and The Wellcome Foundation, (Now part of GSK).
Bob has a wide ranging experience of market research methods, and has presented various papers and chaired training workshops on a variety of topics, including brand positioning, research through the lifecycle, insight generation, and quantitative techniques, including conjoint, pricing and segmentation.
He also served on the EPhMRA Executive Board for several years and has twice won the EPhMRA President's Award, for Contribution to Healthcare Market Research.

Bob

Iain
Iain loves working at the intersect of complex science and evolving customer needs in an ever-changing, increasingly digital world. Iain has significant experience in both agency and client-side marketing roles across a diverse range of customers, specialties and therapeutic areas in the healthcare sector, with an increasing focus on Oncology. His broad commercial experience has been established through commercial roles in business analysis, forecasting, sales, business planning, multichannel strategy, digital strategy and innovation.

Iain

David
A molecular biologist by training, David has 20 years’ scientific experience and brings a thirst for research and rigour in analysis.
David specializes in research and copywriting. He has researched and written several case studies on the development journeys of personalised healthcare medicines, which have been very well received by clients.

David

Alison
With an eye for detail and a passion for analysis, Alison draws on her 14 years' experience of leveraging market research sources to simplify data so that it is meaningful to others.
She loves creating forecast models, analysing markets, and producing market overviews – essentially synthesizing all that is out there to help clients make more informed business decisions. Alison places particular emphasis on providing clear and focused deliverables that are easy for the client to work with and interrogate.
She has supported brands from preclinical development through Ph II and helped ready them for launch in Ph III.

Alison